ADMA Biologics Q3 Adj. EPS $0.23 Beats $0.20 Estimate, Sales $141.102M Beat $138.190M Estimate
Benzinga Newsdesk 4 hours ago
NewsEarningsEarnings Beats
ADMA Biologics (NASDAQ:ADMA) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.20 by 15 percent. This is a 43.75 percent increase over earnings of $0.16 per share from the
ADMA Biologics (NASDAQ:ADMA) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.20 by 15 percent. This is a 43.75 percent increase over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $141.102 million which beat the analyst consensus estimate of $138.190 million by 2.11 percent. This is a 5.12 percent increase over sales of $134.224 million the same period last year.